IMMX
Price
$2.17
Change
-$0.07 (-3.12%)
Updated
Jun 27 closing price
Capitalization
60.08M
67 days until earnings call
XERS
Price
$4.70
Change
-$0.04 (-0.84%)
Updated
Jun 27 closing price
Capitalization
752.73M
39 days until earnings call
Interact to see
Advertisement

IMMX vs XERS

Header iconIMMX vs XERS Comparison
Open Charts IMMX vs XERSBanner chart's image
Immix Biopharma
Price$2.17
Change-$0.07 (-3.12%)
Volume$171.35K
Capitalization60.08M
Xeris Biopharma Holdings
Price$4.70
Change-$0.04 (-0.84%)
Volume$4.69M
Capitalization752.73M
IMMX vs XERS Comparison Chart in %
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMX vs. XERS commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and XERS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (IMMX: $2.15 vs. XERS: $4.70)
Brand notoriety: IMMX and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 91% vs. XERS: 162%
Market capitalization -- IMMX: $60.08M vs. XERS: $752.73M
IMMX [@Biotechnology] is valued at $60.08M. XERS’s [@Biotechnology] market capitalization is $752.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, IMMX is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 4 TA indicator(s) are bullish while XERS’s TA Score has 5 bullish TA indicator(s).

  • IMMX’s TA Score: 4 bullish, 5 bearish.
  • XERS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XERS is a better buy in the short-term than IMMX.

Price Growth

IMMX (@Biotechnology) experienced а -3.79% price change this week, while XERS (@Biotechnology) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

IMMX is expected to report earnings on Sep 03, 2025.

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($753M) has a higher market cap than IMMX($60.1M). XERS YTD gains are higher at: 38.643 vs. IMMX (-2.045). XERS has higher annual earnings (EBITDA): -4.34M vs. IMMX (-21.62M). XERS has more cash in the bank: 58.4M vs. IMMX (15.9M). IMMX has less debt than XERS: IMMX (1.06M) vs XERS (269M). XERS has higher revenues than IMMX: XERS (223M) vs IMMX (0).
IMMXXERSIMMX / XERS
Capitalization60.1M753M8%
EBITDA-21.62M-4.34M498%
Gain YTD-2.04538.643-5%
P/E RatioN/AN/A-
Revenue0223M-
Total Cash15.9M58.4M27%
Total Debt1.06M269M0%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXXERS
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 25 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASLE6.080.06
+1.00%
AerSale Corp
VZ42.310.19
+0.45%
Verizon Communications
CUBI58.980.06
+0.10%
Customers Bancorp
GANX1.95N/A
N/A
Gain Therapeutics
AN198.94-1.09
-0.54%
AutoNation

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and IMTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and IMTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-3.79%
IMTX - IMMX
32%
Poorly correlated
-3.04%
COGT - IMMX
32%
Poorly correlated
-3.07%
XERS - IMMX
32%
Poorly correlated
-0.84%
RNAC - IMMX
31%
Poorly correlated
-7.20%
SYRE - IMMX
31%
Poorly correlated
-4.99%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-0.84%
TRDA - XERS
51%
Loosely correlated
-1.57%
XNCR - XERS
45%
Loosely correlated
-3.10%
YMAB - XERS
45%
Loosely correlated
-1.88%
CGON - XERS
45%
Loosely correlated
-0.46%
AURA - XERS
44%
Loosely correlated
-0.16%
More